Project Overview: Problems of unknown difficulty

Owen Cotton-Barratt

Over the past few months we’ve written a variety of pieces which fit together to give a picture of how we might estimate cost-effectiveness for research and similar activities. This page collects them, summarises what’s contained in each, and explains how they fit together.

  • I gave an overview of my thinking at the Good Done Right conference, held in Oxford in July 2014. The slides and audio of my talk are available; I have developed more sophisticated models for some parts of the area since then.
  • How to treat problems of unknown difficulty introduces the problem: we need to make decisions about when to work more on problems such as research into fusion where we don’t know how difficult it will be. It builds some models which allow principled reasoning about how we should act. These models are quite crude but easy to work with: they are intended to lower the bar for Fermi estimates and similar, and provide a starting point for building more sophisticated models.
  • Estimating cost-effectiveness for problems of unknown difficulty picks up from the models in the above post, and asks what they mean for the expected cost-effectiveness of work on the problems. This involves building a model of the counterfactual impact, as solvable research problems are likely to be solved eventually, so the main effect is to move the solution forwards. This post includes several explicit formulae that you can use to produce estimates; it also explains analogies between the explicit model we derive and the qualitative ‘three factor’ model that GiveWell and 80,000 Hours have used for cause selection.
  • Estimating the cost-effectiveness of research into neglected diseases is an investigation by Max Dalton, which uses the techniques for estimating cost-effectiveness to provide ballpark figures for how valuable we should expect research into vaccines or treatments for neglected diseases to be. The estimates suggest that, if carefully targeted, such research could be more cost-effective than the best direct health interventions currently available for funding.
  • The law of logarithmic returns discusses the question of returns to resources into a field rather than on a single question. With some examples, it suggests that as a first approximation it is often reasonable to assume that diminishing marginal returns take a logarithmic form.
  • Theory behind logarithmic returns explains how some simple generating mechanisms can produce roughly logarithmic returns. This is a complement to the above article: we think having both empirical and theoretical justification for the rule helps us to have higher confidence in it, and to better understand when it’s appropriate to generalise to new contexts. In this piece I also highlight areas for further research on the theoretical side, into when the approximation will break down, and what we might want to use instead in these cases.
  • How valuable is medical research? written with Giving What We Can, applies the logarithmic returns model together with counterfactual reasoning to produce an estimate for the cost-effectiveness of medical research as a whole.

 

Posted in Prioritisation research, Problems of uncertain difficulty, Research notes.

Leave a Reply

Your email address will not be published. Required fields are marked *